Sulfuric Acid

Sulfuric Acid

SCHEMBL2018273

O=S(=O)(O)O.O=S(=O)(O)OOS(=O)(=O)O

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.91
CA5A P35218 2/20 0.55
CA5B Q9Y2D0 2/20 0.55
TSHR P16473 3/20 0.46
TDP1 Q9NUW8 1/20 0.46
CA1 P00915 1/20 0.36
NT5E P21589 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
BLM P54132 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL10426930 1.00 CA2 (0.91) CA2CA5ACA5BTSHRTDP1
Sulfuric Acid SCHEMBL199894 0.96 CA2 (0.83) CA2CA5ACA5BTSHRTDP1
Sulfuric Acid SCHEMBL13370066 0.96 CA2 (0.83) CA2CA5ACA5BTSHRTDP1
Sulfuric Acid SCHEMBL11761606 0.96 CA2 (0.83) CA2CA5ACA5BTSHRTDP1
SCHEMBL9727127 0.95 CA2 (1.00) CA2CA5ACA5BTSHRTDP1
SCHEMBL11043311 0.95 CA2 (1.00) CA2CA5ACA5BTSHRTDP1
SCHEMBL7217 0.95 CA2 (1.00) CA2CA5ACA5BTSHRTDP1
Sulfuric Acid SCHEMBL28324173 0.92 CA2 (0.77) CA2CA5ACA5BTSHRTDP1
Ammonia Solution, Strong SCHEMBL10798362 0.91 CA2 (0.91) CA2CA5ACA5BTSHRTDP1
Ammonia Solution, Strong SCHEMBL7194889 0.91 CA2 (0.91) CA2CA5ACA5BTSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115159870-A Induction-heating coagulation accelerating cementing material and excitation method thereof 武汉理工大学 2022-10-11 CN claimed
EP-3152039-B1 METHOD FOR THE PRODUCTION OF HIGH INTERNAL PHASE EMULSION FOAMS PROCTER & GAMBLE (US) 2021-04-21 EP claimed
US-10752710-B2 Process for the production of high internal phase emulsion foams THE PROCTER & GAMBLE COMPANY (US) 2020-08-25 US claimed
CN-107438627-B Process for producing high internal phase emulsion foams 宝洁公司 2020-07-03 CN claimed
US-20190048111-A1 PROCESS FOR THE PRODUCTION OF HIGH INTERNAL PHASE EMULSION FOAMS PROCTER & GAMBLE (US) 2019-02-14 US claimed
CN-108430384-A Thin flexible electric oral care device 高露洁-棕榄公司 2018-08-21 CN claimed
EP-3152039-A1 METHOD FOR THE PRODUCTION OF HIGH INTERNAL PHASE EMULSION FOAMS The Procter & Gamble Company (US) 2017-04-12 EP claimed
US-9574058-B2 Method for the production of high internal phase emulsion foams THE PROCTER & GAMBLE COMPANY (US) 2017-02-21 US claimed
US-20150353699-A1 METHOD FOR THE PRODUCTION OF HIGH INTERNAL PHASE EMULSION FOAMS THE PROCTER & GAMBLE COMPANY 2015-12-10 US claimed
WO-2015188088-A1 METHOD FOR THE PRODUCTION OF HIGH INTERNAL PHASE EMULSION FOAMS THE PROCTER & GAMBLE COMPANY (US) 2015-12-10 WO claimed
WO-2005061549-A1 CARBOXY-REDUCED DERIVATIVES OF DERMATAN SULPHATE, METHOD OF PREPARING SAID DERIVATIVES, APPLICATION THEREOF AS A MEDICAMENT AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AVENTIS PHARMA S.A. (FR) 2005-07-07 WO claimed
US-12036105-B2 Packaged feminine hygiene pad product adapted for discreet carry and access, and manufacturing process THE PROCTER & GAMBLE COMPANY (US) 2024-07-16 US disclosed
US-12029634-B2 Packaged feminine hygiene pad product adapted for discreet carry and access, and manufacturing process THE PROCTER & GAMBLE COMPANY (US) 2024-07-09 US disclosed
CN-115161641-B Etching solution additive, etching solution, application of etching solution and etching process 苏州迈为科技股份有限公司 2024-06-11 CN disclosed
US-11969325-B2 Absorbent article with function-formed topsheet, and method for manufacturing THE PROCTER & GAMBLE COMPANY (US) 2024-04-30 US disclosed
CN-87100720-A The photosensitive composition that contains microgel 1987-08-26 CN disclosed
EP-0230936-A2 Photosensitive compositions containing microgels E.I. DU PONT DE NEMOURS AND COMPANY (US) 1987-08-05 EP disclosed
US-4520074-A SURFACE COATINGS FOR RESINOUS ARTICLES GENERAL ELECTRIC COMPANY (US) 1985-05-28 US disclosed
US-4035564-A Polymerization process for producing polychloroprene particles MONSANTO COMPANY (US) 1977-07-12 US disclosed
US-4022733-A LATEX SEED PARTICLES MONSANTO COMPANY (US) 1977-05-10 US disclosed